Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

IPCA Laboratories: Emkay Global sees 21% upside; projects 12–13% FY27 sales growth

  • Posted on June 3, 2026
  • By Financial Express
  • 0 Views
  • 1 min read
IPCA Laboratories: Emkay Global sees 21% upside; projects 12–13% FY27 sales growth
IPCA Laboratories: Emkay Global sees 21% upside; projects 12–13% FY27 sales growth

Emkay Global sees 21% upside for IPCA Labs, fueled by strong earnings and sales growth. Discover why analysts rate it a 'Buy' now!
continue reading...

Author
Financial Express

You May Also Like